Clinical study shows long-term survival of metastatic melanoma significantly improves with immunotherapy – Medical Xpress

by
  1. Clinical research shows that long-term survival of metastatic melanoma is significantly improved with immunotherapyMedical Xpress
  2. Half of patients with advanced melanoma survive for 10 years with dual drug therapyThe guard
  3. New skin cancer treatment helps patients live 10 years after diagnosis, study findsThe Telegraph
  4. Immunotherapy drugs extend survival of patients with advanced melanomasUS News & World Report
  5. Neoadjuvant immunotherapy is better than targeted therapy in stage III melanomaAJMC.com Managed Markets Network

Leave a Comment